BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37933466)

  • 1. Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle.
    Nelson MR; Zhang X; Podgaetz E; Wang X; Zhang Q; Pan Z; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2024 Jan; 326(1):G38-G52. PubMed ID: 37933466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
    Odiase E; Zhang X; Chang Y; Nelson M; Balaji U; Gu J; Zhang Q; Pan Z; Spechler SJ; Souza RF
    Gastroenterology; 2021 May; 160(6):2072-2088.e6. PubMed ID: 33581123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
    Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
    PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
    Cheng E; Zhang X; Huo X; Yu C; Zhang Q; Wang DH; Spechler SJ; Souza RF
    Gut; 2013 Jun; 62(6):824-32. PubMed ID: 22580413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.
    Zhang X; Cheng E; Huo X; Yu C; Zhang Q; Pham TH; Wang DH; Spechler SJ; Souza RF
    PLoS One; 2012; 7(11):e50037. PubMed ID: 23185525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
    Park JY; Zhang X; Nguyen N; Souza RF; Spechler SJ; Cheng E
    PLoS One; 2014; 9(7):e101391. PubMed ID: 24988451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
    Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
    Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
    Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.
    Beppu LY; Anilkumar AA; Newbury RO; Dohil R; Broide DH; Aceves SS
    J Allergy Clin Immunol; 2014 Nov; 134(5):1100-1107.e4. PubMed ID: 24835503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors.
    Rochman M; Xie YM; Mack L; Caldwell JM; Klingler AM; Osswald GA; Azouz NP; Rothenberg ME
    J Allergy Clin Immunol; 2021 May; 147(5):1924-1935. PubMed ID: 33289661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.
    Rieder F; Nonevski I; Ma J; Ouyang Z; West G; Protheroe C; DePetris G; Schirbel A; Lapinski J; Goldblum J; Bonfield T; Lopez R; Harnett K; Lee J; Hirano I; Falk G; Biancani P; Fiocchi C
    Gastroenterology; 2014 May; 146(5):1266-77.e1-9. PubMed ID: 24486052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical differentiation of eosinophilic esophageal myositis from eosinophilic esophagitis.
    Sato H; Nakajima N; Hasegawa G; Kawata Y; Sato Y; Suzuki K; Honma T; Terai S
    J Gastroenterol Hepatol; 2017 Jan; 32(1):106-113. PubMed ID: 27262491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 Cytokines Promote the Secretion of the Eosinophil-Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients.
    Vaccaro J; Canziani KE; Guzmán L; Bernedo V; García M; Altamirano EM; Feregotti E; Curciarello R; Muglia CI; Docena GH
    Front Immunol; 2022; 13():909896. PubMed ID: 35799778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.
    Gupta SK; Fitzgerald JF; Kondratyuk T; HogenEsch H
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):22-6. PubMed ID: 16385249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
    Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
    Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma, IL-4 and IL-13 modulate responsiveness of human airway smooth muscle cells to IL-13.
    Moynihan BJ; Tolloczko B; El Bassam S; Ferraro P; Michoud MC; Martin JG; Laberge S
    Respir Res; 2008 Dec; 9(1):84. PubMed ID: 19116009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
    Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
    Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A striking local esophageal cytokine expression profile in eosinophilic esophagitis.
    Blanchard C; Stucke EM; Rodriguez-Jimenez B; Burwinkel K; Collins MH; Ahrens A; Alexander ES; Butz BK; Jameson SC; Kaul A; Franciosi JP; Kushner JP; Putnam PE; Abonia JP; Rothenberg ME
    J Allergy Clin Immunol; 2011 Jan; 127(1):208-17, 217.e1-7. PubMed ID: 21211656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Human Esophageal Epithelial and Muscle Cells Treated With Th2 Cytokines, Upadacitinib Decreases Eotaxin-3 Secretion and Muscle Tension.
    Nelson M; Zhang X; Podgaetz E; Melmed A; Spechler SJ; Souza RF
    Gastroenterology; 2024 Jun; 166(6):1166-1169.e3. PubMed ID: 38364911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.